Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last A$96.17 AUD
Change Today +1.52 / 1.61%
Volume 1.6M
As of 2:11 AM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Brian A. McNamee MB, BS, FAICD, FTSE

Former Executive Director and Member of Innovation & Development Committee, CSL Ltd.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 5 different industries.

See Board Relationships
58--
As of Fiscal Year 2014

Background*

Dr. Brian A. McNamee AO, MBBS, FAICD, FTSE serves as the Chief Executive Officer and Managing Director of CSL Biotherapies, Inc. Dr. McNamee serves as the President of CSL (US) Inc. He serves as an Advisor at KKR & Co. L.P. and advises on deals in the healthcare sector globally. He is a Special Adviser to the board and managing director of GenesisCare. He served as the Chief Executive Officer and Managing Director of CSL Ltd. from 1990 to July 1, 2013. Prior to 1990, ...

Read Full Background

Corporate Headquarters*

45 Poplar Road
Parkville, Victoria 3052

Australia

Phone: 61 3 9389 1911
Fax: 61 3 9389 1434

Board Members Memberships*

Chief Executive Officer, Managing Director and Executive Director

Education*

Bachelor's Degree 1979
The University of Melbourne

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CSL:AU A$96.17 AUD +1.52

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CSL LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.